You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ly2216684

Showing 1 - 25 of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD Trial in Evansville (LY2216684, Placebo-matching LY2216684, Placebo-matching alcoholic beverage)

Completed
Has Results
  • Major Depressive Disorder
  • LY2216684
  • +3 more
  • Evansville, Indiana
    For additional information regarding investigative sites for thi
Apr 1, 2019

MDD Trial in Dallas (LY2216684, Theophylline)

Completed
Has Results
  • Major Depressive Disorder
  • Dallas, Texas
    For additional information regarding investigative sites for thi
Apr 16, 2019

MDD Trial in Leeds (LY2216684, Placebo, Lorazepam)

Completed
Has Results
  • Major Depressive Disorder
  • LY2216684
  • +2 more
  • Leeds, United Kingdom
    For additional information regarding investigative sites for thi
Nov 9, 2018

MDD Trial in Evansville (LY2216684, albuterol, propranolol)

Completed
Has Results
  • Major Depressive Disorder
  • LY2216684
  • +5 more
  • Evansville, Indiana
    For additional information regarding investigative sites for thi
Jan 9, 2019

MDD Trial in Dallas (Warfarin, LY2216684)

Completed
Has Results
  • Major Depressive Disorder
  • Dallas, Texas
    For additional information regarding investigative sites for thi
Jan 9, 2019

MDD Trial in Evansville (LY2216684, Fluoxetine)

Completed
Has Results
  • Major Depressive Disorder
  • Evansville, Indiana
    For additional information regarding investigative sites for thi
Jan 9, 2019

MDD Trial in Daytona Beach (LY2216684, Sertraline)

Completed
Has Results
  • Major Depressive Disorder
  • Daytona Beach, Florida
    For additional information regarding investigative sites for thi
Dec 13, 2018

Depressive Disorder, Major Trial in Dallas (LY2216684, Activated Charcoal)

Completed
Has Results
  • Depressive Disorder, Major
  • LY2216684
  • Activated Charcoal
  • Dallas, Texas
    For additional information regarding investigative sites for thi
Dec 13, 2018

Depressive Disorder, Major Trial in Daytona Beach (LY2216684)

Completed
Has Results
  • Depressive Disorder, Major
  • LY2216684
  • Daytona Beach, Florida
    For additional information regarding investigative sites for thi
Nov 9, 2018

Depressive Disorder, Major Trial in Madison (LY2216684, Ortho Cyclen, Placebo)

Completed
Has Results
  • Depressive Disorder, Major
  • LY2216684
  • +2 more
  • Madison, Wisconsin
    For additional information regarding investigative sites for thi
Mar 26, 2018

MDD Trial in Daytona Beach (LY2216684, Digoxin)

Completed
Has Results
  • Major Depressive Disorder
  • Daytona Beach, Florida
    For additional information regarding investigative sites for thi
Mar 26, 2018

Depressive Disorder, Major Trial in Dallas (LY2216684, Quinidine)

Completed
Has Results
  • Depressive Disorder, Major
  • Dallas, Texas
    For additional information regarding investigative sites for thi
Mar 26, 2018

MDD Trial in Dallas (Clopidogrel, LY2216684)

Completed
Has Results
  • Major Depressive Disorder
  • Dallas, Texas
    For additional information regarding investigative sites for thi
Mar 26, 2018

Depressive Disorder, Major Trial in Daytona Beach (LY2216684, Clarithromycin)

Completed
Has Results
  • Depressive Disorder, Major
  • Daytona Beach, Florida
    For additional information regarding investigative sites for thi
Mar 26, 2018

MDD Trial in Saint Louis, Austin (LY2216684, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • LY2216684
  • Placebo
  • Saint Louis, Missouri
  • +1 more
Mar 26, 2018

Depressive Disorder, Major Trial in Miami, Orlando, San Antonio (LY2216684)

Completed
Has Results
  • Depressive Disorder, Major
  • LY2216684
  • Miami, Florida
  • +2 more
Mar 26, 2018

MDD Trial in Japan (LY2216684, SSRI)

Completed
Has Results
  • Major Depressive Disorder
  • Chiba, Japan
  • +8 more
Mar 26, 2018

MDD Trial in Romania, United States (LY2216684, Placebo, Escitalopram)

Completed
Has Results
  • Major Depressive Disorder
  • LY2216684
  • +2 more
  • Orlando, Florida
  • +6 more
Mar 26, 2018

MDD (MDD) Trial in Worldwide (LY2216684, Placebo, SSRI)

Completed
Has Results
  • Major Depressive Disorder (MDD)
  • LY2216684
  • +2 more
  • Birmingham, Alabama
  • +53 more
Mar 25, 2018

MDD Trial in Worldwide (LY2216684, Placebo, SSRI)

Completed
Has Results
  • Major Depressive Disorder
  • LY2216684
  • +2 more
  • Irvine, California
  • +62 more
Mar 17, 2018

MDD Trial in Worldwide (LY2216684, Placebo, SSRI)

Completed
Has Results
  • Major Depressive Disorder
  • LY2216684
  • +2 more
  • Redlands, California
  • +76 more
Mar 16, 2018

Depressive Disorder, Major Trial in United States (LY2216684, Placebo)

Completed
Has Results
  • Depressive Disorder, Major
  • LY2216684
  • Placebo
  • Birmingham, Alabama
  • +23 more
Mar 25, 2018

MDD Trial in Worldwide (LY2216684, Placebo, SSRI)

Completed
Has Results
  • Major Depressive Disorder
  • LY2216684
  • +2 more
  • Garden Grove, California
  • +48 more
Mar 26, 2018

Depressive Disorder, Major Trial in Worldwide (LY2216684, Placebo)

Completed
Has Results
  • Depressive Disorder, Major
  • LY2216684
  • Placebo
  • Birmingham, Alabama
  • +36 more
Mar 16, 2018

ADHD Trial in Canada, Puerto Rico, United States (LY2216684, Methylphenidate, Placebo (tablet))

Completed
Has Results
  • Attention Deficit Hyperactivity Disorder
  • LY2216684
  • +3 more
  • Spring Valley, California
  • +18 more
Jul 29, 2014